1 CDC Centers for Disease Control and Prevention https://www.cdc.gov/tobacco/basic_information/e-cigarettes/about-e-cigarettes.html.
2 Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin – Final Report. N Engl J Med. 2020;382:903–16.
3 Schier JG, Meiman JG, Layden J, et al. Severe Pulmonary Disease Associated with Electronic-Cigarette-Product Use – Interim Guidance. MMWR Morb Mortal Wkly Rep. 2019;68:787–90.
4 Macias AE, Garcia FJ, Saldana SG. A patient from Mexico with vaping-associated lung injury, seizures and renal failure. Tob Induc Dis. 2019;17:91.
5 Bolona E, Felix M, Vanegas E, Vera Paz C, Cherrez-Ojeda I. A Case of Vaping-associated Pulmonary Illness in South America: Highlighting the Need for Awareness and Surveillance Programs in the Region. Am J Respir Crit Care Med. 2020;201:733–5.
6 Casanova GS, Amaro R, Soler N, et al. An imported case of e-cigarette or vaping associated lung injury (EVALI) in Barcelona. Eur Respir J. 2019.
7 Marliere C, De Greef J, Gohy S, et al. Fatal e-cigarette or vaping associated lung injury (EVALI): a first case report in Europe. Eur Respir J. 2020.
8 Villeneuve T, Prevot G, Le Borgne A, et al. Diffuse alveolar haemorrhage secondary to e-cigarette “vaping” associated lung injury (EVALI) in a young European consumer. Eur Respir J 2020.
9 Suhling H, Welte T, Fuehner T. Three Patients With Acute Pulmonary Damage Following the Use of E-Cigarettes-A Case Series. Dtsch Arztebl Int. 2020;117:177–82.
10 Krishnasamy VP, Hallowell BD, Ko JY, et al. Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury – United States, August 2019-January 2020. MMWR Morb Mortal Wkly Rep. 2020;69:90-4.
11 Ellington S, Salvatore PP, Ko J, et al. Update: Product, Substance-Use, and Demographic Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020. MMWR Morb Mortal Wkly Rep. 2020;69:44–9.
12 Layden JE, Ghinai I, Pray I, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report. N Engl J Med. 2020;382:903–16.
13 Blagev DP, Harris D, Dunn AC, Guidry DW, Grissom CK, Lanspa MJ. Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study. Lancet. 2019;394:2073–83.
14 Kalininskiy A, Bach CT, Nacca NE, et al. E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach. Lancet Respir Med. 2019;7:1017–26.
15 Heinzerling A, Armatas C, Karmarkar E, et al. Severe Lung Injury Associated With Use of e-Cigarette, or Vaping, Products-California, 2019. JAMA Intern Med. 2020.
16 Triantafyllou GA, Tiberio PJ, Zou RH, et al. Vaping-Associated Acute Lung Injury: A Case Series. Am J Respir Crit Care Med. 2019.
17 Sechrist JW, Kanne JP. Vaping-associated Lung Disease. Radiology. 2020;294:18.
18 Kligerman S, Raptis C, Larsen B, et al. Radiologic, Pathologic, Clinical, and Physiologic Findings of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): Evolving Knowledge and Remaining Questions. Radiology. 2020;294:491–505.
19. Artunduaga M, Rao D, Friedman J, et al. Pediatric Chest Radiographic and CT Findings of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI). Radiology. 2020:192778.
20 Drabkin MJ, Heyligers B. Vaping-associated pulmonary disease (VAPD): An unusual pattern of CT findings. Radiol Case Rep. 2020;15:154–5.
21 Thakrar PD, Boyd KP, Swanson CP, Wideburg E, Kumbhar SS. E-cigarette, or vaping, product use-associated lung injury in adolescents: a review of imaging features. Pediatr Radiol. 2020;50:338–44.
22 Aberegg SK, Maddock SD, Blagev DP, Callahan SJ. Diagnosis of EVALI: General Approach and the Role of Bronchoscopy. Chest. 2020.
23 Akkanti BH, Hussain R, Patel MK, et al. Deadly combination of Vaping-lnduced lung injury and Influenza: case report. Diagn Pathol. 2020;15:83.
24 Kooragayalu S, El-Zarif S, Jariwala S. Vaping Associated Pulmonary Injury (VAPI) with superimposed Mycoplasma pneumoniae infection. Respir Med Case Rep. 2020;29:100997.
25 Chen L, Arens R, Chidambaram AG, et al. Vaping Associated Pulmonary Nontuberculous Mycobacteria. Lung. 2021.
26 Gilpin DF, McGown KA, Gallagher K, et al. Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens. Respir Res. 2019;20:267.
27 Callahan SJ, Harris D, Collingridge DS, et al. Diagnosing EVALI in the Time of COVID-19. Chest. 2020;158:2034–7.
28 Russo P, Bonassi S, Giacconi R, Malavolta M, Tomino C, Maggi F. COVID-19 and smoking: is nicotine the hidden link? Eur Respir J. 2020;55.
29 Mukhopadhyay S, Mehrad M, Dammert P, et al. Lung Biopsy Findings in Severe Pulmonary Illness Associated With E-Cigarette Use (Vaping). Am J Clin Pathol. 2020;153:30–9.
30 Butt YM, Smith ML, Tazelaar HD, et al. Pathology of Vaping-Associated Lung Injury. N Engl J Med. 2019;381:1780–1.
31 Blount BC, Karwowski MP, Shields PG, et al. Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI. N Engl J Med. 2020;382:697–705.
32 Wu D, O’Shea DF. Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate. Proc Natl Acad Sci U S A. 2020;117:6349–55.
33 Fryman C, Lou B, Weber AG, et al. Acute Respiratory Failure Associated With Vaping. Chest. 2020;157:e63–e8.
34 Evans ME, Twentyman E, Click ES, et al. Update: Interim Guidance for Health Care Professionals Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury and for Reducing the Risk for Rehospitalization and Death Following Hospital Discharge – United States, December 2019. MMWR Morb Mortal Wkly Rep. 2020;68:1189–94.
35 Werner AK, Koumans EH, Chatham-Stephens K, et al. Hospitalizations and Deaths Associated with EVALI. N Engl J Med. 2020;382:1589–98.
36 Mikosz CA, Danielson M, Anderson KN, et al. Characteristics of Patients Experiencing Rehospitalization or Death After Hospital Discharge in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury – United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;68:1183–8.
37 Zou RH, Tiberio PJ, Triantafyllou GA, et al. Clinical Characterization of E-cigarette, or Vaping, Product Use Associated Lung Injury in 36 Patients in Pittsburgh, PA. Am J Respir Crit Care Med 2020.
38 Ahmad M, Aftab G, Rehman S, Frenia D. Long-term Impact of E-cigarette and Vaping Product Use-associated Lung Injury on Diffusing Capacity for Carbon Monoxide Values: A Case Series. Cureus. 2020;12:e7002.
39 Poschenrieder F, Rotter M, Gschwendtner A, Hamer OW. E-cigarette-induced lung disease: from acute to chronic. Lancet. 2020;396:564.
40 https://www.seco.admin.ch/seco/de/home/Aussenwirtschaftspolitik_Wirtschaftliche_Zusammenarbeit/Wirtschaftsbeziehungen/Technische_Handelshemmnisse/Cassis-de-Dijon-Prinzip.html.
41 https://ec.europa.eu/health/tobacco/products_en.
42 Youmans AJ, Harwood J. Gross and Histopathological Findings in the First Reported Vaping-Induced Lung Injury Death in the United States. Am J Forensic Med Pathol. 2020;41:1–4.
43 Marsden L, Michalicek ZD, Christensen ED. More on the Pathology of Vaping-Associated Lung Injury. N Engl J Med. 2020;382:387–8.
44 Reagan-Steiner S, Gary J, Matkovic E, et al. Pathological findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury (EVALI): a case series. Lancet Respir Med. 2020.
2 Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin – Final Report. N Engl J Med. 2020;382:903–16.
18 Kligerman S, Raptis C, Larsen B, Henry TS, Caporale A, Tazelaar H, et al. Radiologic, Pathologic, Clinical, and Physiologic Findings of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): Evolving Knowledge and Remaining Questions. Radiology. 2020;294(3):491–505.
30 Butt YM, Smith ML, Tazelaar HD, Vaszar LT, Swanson KL, Cecchini MJ, et al. Pathology of Vaping-Associated Lung Injury. N Engl J Med. 2019;381(18):1780–1.
31 Blount BC, Karwowski MP, Shields PG, Morel-Espinosa M, Valentin-Blasini L, Gardner M, et al; Lung Injury Response Laboratory Working Group. Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI. N Engl J Med. 2020;382(8):697–705.
34 Evans ME, Twentyman E, Click ES, Goodman AB, Weissman DN, Kiernan E, et al; Lung Injury Response Clinical Task Force; Lung Injury Response Clinical Working Group. Update: Interim Guidance for Health Care Professionals Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury and for Reducing the Risk for Rehospitalization and Death Following Hospital Discharge – United States, December 2019. MMWR Morb Mortal Wkly Rep. 2020;68(5152):1189–94.